Market Overview

Benzinga's Top Upgrades, Downgrades For August 29, 2017

Share:

Top Upgrades

  • Wedbush upgraded Kite Pharma Inc (NASDAQ: KITE) from Underperform to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Analysts at Wedbush upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Neutral to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.
  • Bank of America upgraded Heico Corp (NYSE: HEI) from Neutral to Buy. HEICO shares dropped 1.30 percent to close at $83.25 on Monday.
  • Analysts at Raymond James upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Market Perform to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.


Top Downgrades

  • Analysts at FBR Capital downgraded Finish Line Inc (NASDAQ: FINL) from Buy to Neutral. Finish Line shares fell 29.6 percent to $7.34 in pre-market trading.
  • Canaccord Genuity downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Chardan Capital downgraded Intellia Therapeutics Inc (NASDAQ: NTLA) from Buy to Neutral. Intellia Therapeutics shares dropped 2.45 percent to $20.31 in pre-market trading.
  • Axiom Capital downgraded JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Hold to Sell. JA Solar shares closed at $6.38 on Monday.
  • BTIG downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Analysts at Bank of America downgraded Cemex SAB de CV (ADR) (NYSE: CX) from Buy to Neutral. Cemex shares fell 0.11 percent to close at $9.12 on Monday.
  • JMP Securities downgraded Loxo Oncology Inc (NASDAQ: LOXO) from Market Outperform to Market Perform. Loxo Oncology shares rose 5.89 percent to close at $78.56 on Monday.
  • SunTrust Robinson Humphrey downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.

 


Top Initiations

 

  • Analysts at Macquarie initiated coverage on Carter's, Inc. (NASDAQ: CRI) with an Outperform rating. Carter's shares closed at $85.92 on Monday.
  • Brean Capital initiated coverage on CenterState Banks Inc (NASDAQ: CSFL) with a Hold rating. CenterState Banks shares closed at $24.73 on Monday.
  • Nomura initiated coverage on AveXis Inc (NASDAQ: AVXS) with a Reduce rating. The price target for AveXis is set to $52. AveXis shares closed at $96.98 on Monday.
  • Analysts at Chardan Capital initiated coverage on Tivity Health Inc (NASDAQ: TVTY) with a Neutral rating. The price target for Tivity Health is set to $40. Tivity Health shares closed at $37.55 on Monday.
  • KLR Group initiated coverage on Ultra Petroleum Corp. (NYSE: UPL) with a Buy rating. The price target for Ultra Petroleum is set to $14. Ultra Petroleum shares closed at $7.61 on Monday.
  • Analysts at Citi initiated coverage of Venator Materials PLC (NYSE: VNTR) with a Buy rating. The price target for Venator Materials is set to $24. Venator Materials shares closed at $20.05 on Monday.
  • Analysts at Aegis Capital initiated coverage on DarioHealth Corp (NASDAQ: DRIO) with a Buy rating. The price target for DarioHealth is set to $3.50. DarioHealth shares closed at $2.00 on Monday.
  • Bank of America initiated coverage on Helen of Troy Limited (NASDAQ: HELE) with an Underperform rating. The price target for Helen of Troy is set to $87. Helen of Troy shares closed at $96.85 on Monday.

Latest Ratings for KITE

DateFirmActionFromTo
Aug 2017UpgradesUnderperformNeutral
Aug 2017DowngradesBuyHold
Aug 2017DowngradesBuyHold

View More Analyst Ratings for KITE
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (CRI + AVXS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MUCascendReiterates65.0
ALDRCanaccord GenuityDowngrades20.0
LEGHLake StreetInitiates Coverage On21.0
CHUGoldman SachsUpgrades13.2
STZBMO CapitalMaintains230.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Finish Line's Shin Splints: Poor Quarterly Pre-Announcement Pummels Stock, Downgrade Follows

What Has More Leaks Than The White House? M&A Deals